Results Post hoc epigenetic age analysis of a randomized trial of semaglutide To determine whether semaglutide treatment could impact biological aging, we conducted a post hoc epigenetic analysis of participants enrolled in a previously reported 32-week, randomized, double-blind, placebo-controlled phase 2b clinical trial (NCT04019197) evaluating semaglutide in PWH and lipohypertrophy 19 (Fig
2ac, Supplementary Materials & Methods Table S2)
Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Praschak-Rieder N, Sitte HH, et al
Saha B, Kamalumpundi V, Codipilly DC
There are a number of reasons you dont want to lose muscle mass (beyond looking great in a gym selfie): Muscle provides critical strength and stability to your bones and joints
About Kelly Dorfman MS LND Kelly Dorfman is one of the worlds foremost experts on using nutrition therapeutically to improve brain function, energy and mood